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Trib2 regulates the pluripotency of embryonic stem
cells and enhances reprogramming efﬁciency
Eun Kyoung Do1, Jae Kyung Park1, Hyo Cheon Cheon1, Yang Woo Kwon1, Soon Chul Heo1, Eun Jung Choi1,
Jeong Kon Seo2, Il Ho Jang3, Sang Chul Lee4 and Jae Ho Kim1,5
Embryonic stem (ES) cells are pluripotent cells characterized by self-renewability and differentiation potential. Induced
pluripotent stem (iPS) cells are ES cell-equivalent cells derived from somatic cells by the introduction of core reprogramming
factors. ES and iPS cells are important sources for understanding basic biology and for generating therapeutic cells for clinical
applications. Tribbles homolog 2 (Trib2) functions as a scaffold in signaling pathways. However, the relevance of Trib2 to the
pluripotency of ES and iPS cells is unknown. In the present study, we elucidated the importance of Trib2 in maintaining
pluripotency in mouse ES cells and in generating iPS cells from somatic cells through the reprogramming process. Trib2
expression decreased as ES cells differentiated, and Trib2 knockdown in ES cells changed their colony morphology while
reducing the activity of alkaline phosphatase and the expression of the pluripotency marker genes Oct4, Sox2, Nanog and Klf4.
Trib2 directly interacted with Oct4 and elevated Oct4 promoter activity. During the generation of iPS cells, Trib2 knockdown
decreased the reprogramming efﬁciency of mouse embryonic ﬁbroblasts, whereas Trib2 overexpression signiﬁcantly increased
their reprogramming efﬁciency. In summary, our results suggest that Trib2 is important for maintaining self-renewal in ES cells
and for pluripotency induction during the reprogramming process.
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INTRODUCTION
Pluripotent cells have drawn major attention due to their
nearly unlimited self-renewal potential and their ability to
differentiate into all types of cells in the body.1,2 They are
broadly classiﬁed into two main groups: embryonic stem (ES)
cells, which are derived from the inner cell masses (ICMs) of
mammalian blastocysts, and induced pluripotent stem (iPS)
cells, which can be generated from somatic cells by introducing
deﬁned transcription factors, such as Oct4, Sox2, Klf4 and c-
Myc.3 iPS cells are molecularly and functionally similar to ES
cells.4,5 ES cells and iPS cells are attractive for therapeutic
applications due to their unlimited potential to self-renew and
differentiate.6–8 Therefore, an understanding of the molecular
mechanism underlying pluripotency induction and mainte-
nance has a signiﬁcant impact on basic biology and on clinical
applications for treating various diseases using regenerative
medicine.
Tribbles homolog 2 (Trib2) is a member of the Tribbles
family, and members of this family act as adaptors or
scaffolds in signaling pathways.9 Trib2 is located mostly in
the cytoplasm of several types of cells.10 In lung cancer,
Trib2 interacts with TRIM21, an E3 ubiquitin ligase that
degrades C/EBPα, which inhibits tumor growth in vivo.
Trib2 knockdown leads to morphological changes
in lung cancer cells that resemble C/EBPα overexpression.11
Trib2 is associated with cancer progression and tumorigenesis.
Trib2 is highly expressed in malignant melanoma, and silencing
Trib2 decreases colony formation and migration ability.12
Although Trib2 is implicated in multiple important cellular
processes, its relevance in pluripotency regulation has not been
reported.
In the present study, for the ﬁrst time, we have
examined the roles of Trib2 in maintaining the
self-renewal of ES cells and inducing somatic cell pluripotency
through the reprogramming process. This research
demonstrates a novel function of Trib2 in regulating pluripo-
tency and describes the mechanism of Trib2 and Oct4
interaction.
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MATERIALS AND METHODS
Materials
Dulbecco's modiﬁed Eagle medium (DMEM), non-essential amino
acids, Glutamax-1, fetal bovine serum (FBS) trypsin, Lipofectamine-
plus, Blasticidin and the Alexa Fluor 488 goat anti-rabbit (A-11034),
Alexa Fluor 488 goat anti-mouse (A-11029), Alexa Fluor 488 donkey
anti-goat (A-11055), and Alexa Fluor 568 goat anti-rabbit (A-11011)
antibodies were purchased from Thermo Fisher Scientiﬁc (Waltham,
MA, USA). Leukemia inhibitory factor (LIF), the anti-GAPDH anti-
body (MAB374), and a control antibody for chromatin immunopre-
cipitation (NI02) were purchased from EMD Millipore Corp.
(Billerica, MA, USA). Penicillin-streptomycin was purchased from
HyClone (Logan, UT, USA). Culture plates were purchased from
Nunc (Roskilde, Denmark). Vectashield mounting medium with
4′-6-Diamidino-2-phenylindole was purchased from Vector Labora-
tories (Burlingame, CA, USA). Peroxidase-labeled secondary antibo-
dies and enhanced chemiluminescence Western blotting detection
reagents were purchased from Amersham Biosciences (Pittsburgh, PA,
USA). The pNTAP vector (#240101) was purchased from Stratagene
(La Jolla, CA, USA). Streptavidin resin (#240105) was purchased from
Agilent Technologies, Inc. (Santa Clara, CA, USA). The following
antibodies were used in this study: anti-Sox2 (5ab 9776), purchased
from Abcam (Cambridge, MA, USA); anti-Trib2 (15359-1-AP),
purchased from Proteintech Group (Manchester, UK); anti-Nanog
(#8822), purchased from Cell Signaling Technology, Inc. (Danvers,
MA, USA); anti-SSEA-1 (sc-21702), anti-Oct4 (sc-8628), and anti-
Sox2 (sc-17320), purchased from Santa Cruz Biotechnology, Inc.
(Santa Cruz, CA, USA); and anti-FLAG-tag (F9291), purchased from
Sigma-Aldrich (St Louis, MO, USA). The Dual-Luciferase Reporter
Assay System and the pGL3-basic vector (E1751) were purchased from
Promega (Madison, WI, USA). Protease inhibitor cocktail (P8849),
β-mercaptoethanol (M6250), an alkaline phosphatase detection kit
(86R) and all other chemicals were purchased from Sigma-Aldrich.
Cell culture and differentiation assays
D3 and OG2/ROSA26 mouse ES (mES) cells were cultured on
mitomycin C-treated mouse embryonic ﬁbroblasts (MEFs) in ES cell
culture media (DMEM supplemented with 1×non-essential amino
acids, 1 × Glutamax-1, 15% FBS, 1× penicillin-streptomycin, 0.1 mM
β-mercaptoethanol, and 1000 Uml−1 LIF). MEFs were isolated from
12.5-day-old embryos from pregnant C3H mice and maintained in
MEF medium (DMEM with high glucose, 1 ×Glutamax-1, 10% FBS,
and 1× penicillin-streptomycin) as described previously.3 To culture
embryoid bodies (EBs) via the hanging-drop method, 20 μl (50 000
cells per ml) of dissociated ES cells were spotted on a Petri dish lid in
ES cell medium without LIF. After 4 days, EBs were transferred to a
1% gelatin-coated dish to induce their spontaneous differentiation and
then incubated in ES cell medium without LIF for 6 days. Cells were
incubated in a humidiﬁed incubator at 37 °C under 5% CO2.
Gene silencing using shRNA lentivirus
pLKO.1-puro lentiviral vectors expressing Trib2 shRNA
(TRCN0000362058) and non-target control shRNA (SHC002) were
purchased from Sigma-Aldrich. To generate lentiviral particles,
293FT cells were co-transfected with the shRNA lentiviral plasmid
(pLKO.1-puro) and ViraPower Lentiviral Packaging Mix (pLP1, pLP2
and pLP-VSV-G; Thermo Fisher Scientiﬁc, Waltham, MA, USA) using
Lipofectamine-plus and culture supernatants containing lentivirus
collected 48 h after transfection. For lentiviral transduction, D3 mES
cells were treated with culture supernatants from 293FT cells in the
presence of 10 μg ml− 1 polybrene (Sigma-Aldrich), and stable cell
lines expressing shRNA were generated by selection with puromycin
(5 μg ml− 1). To ensure shRNA-mediated Trib2 expression silencing,
the Trib2 and GAPDH mRNA levels were determined by RT-PCR
analysis.
Reverse transcription-PCR (RT-PCR) and quantitative
RT-PCR
Total cellular RNA was extracted using the TRIzol (T9424, Sigma-
Aldrich) method. For RT-PCR analysis, 2 μg of each RNA aliquot were
subjected to cDNA synthesis using 200 U of M-MLV reverse
transcriptase and 0.5 μg of oligo (dT) 15 primer (C-1101, Promega).
cDNA in 2 μl of the reaction mixture was ampliﬁed using 0.5 U of
GoTaq DNA polymerase (M8298, Promega). The thermal cycle was as
follows: denaturation at 95 °C for 30 s, annealing at 52–58 °C for 30 s
depending on the primers used, and extension at 72 °C for 30 s. Each
PCR reaction was carried out for 30 cycles, and the PCR products
were size-fractionated on a 1.2% agarose gel with ethidium bromide
and photographed under UV trans-illumination. Quantitative
RT-PCR was performed on an ABI 7500 (Applied Biosystems)
sequence detection system with SYBR Green PCR Master Mix
(ABS-4309155, Applied Biosystems) according to the manufacturer’s
instructions. Experiments were performed in duplicate, and the data
were normalized to β-actin mRNA expression. Data were analyzed
using the Δ (Δ CT) method and normalized to β-actin. The RT-PCR
primer sequences are listed in Supplementary Table S1.
Western blotting
Cell extracts were treated with the appropriate conditions, washed
with ice-cold phosphate-buffered saline (PBS), and then lysed in lysis
buffer B (20 mM Tris-HCl, 1 mM EGTA, 1 mM EDTA, 10 mM NaCl,
0.5 mM phenylmethylsulfonyl ﬂuoride, 1 mM Na3VO4, 30 mM sodium
pyrophosphate, 25 mM β-glycerol phosphate, 1% Triton X-100,
pH 7.4). Lysates were resolved by SDS-PAGE, transferred onto
nitrocellulose membranes, and stained with 0.1% Ponceau S solution
(P3504, Sigma-Aldrich). After blocking with 5% nonfat milk, the
membranes were immunoblotted with various antibodies, and bound
antibodies were visualized with horseradish peroxidase-conjugated
secondary antibodies using an enhanced chemiluminescence Western
blotting kit (ECL, Amersham Biosciences).
Immunoprecipitation
To immunoprecipitate FLAG-tagged Trib2, TAP-tagged Oct4 and
TAP-tagged Sox2 in 293FT cells, the FLAG-tagged Trib2 and TAP-
tagged Oct4 constructs were transfected into 293FT cells with the
Lipofectamine-plus reagent, and cell lysates were lysed in lysis buffer
A. The cell lysates (1 mg) were then incubated with protein G-sephar-
ose (P3296) conjugated with FLAG-agarose beads (F3165) or strepta-
vidin resin for 2 h at 4 °C on a rotating wheel (all from Sigma-
Aldrich). The beads were washed extensively with lysis buffer A.
Bound proteins were eluted by boiling in 2× SDS sample buffer and
resolved on 10% SDS-PAGE gels for Western blot analysis. Oct4
deletion constructs containing the residues ΔPOU, ΔTAD2, TAD1,
N-half, ΔTAD1, POU, ΔPOUH were generated from p3xFLAG-
CMV-10-Trib2 using the QuickChange-XL site-directed mutagenesis
kit (Stratagene). To immunoprecipitate the FLAG-Oct4 deletion
constructs and TAP-Trib2, they were transfected into 293FT cells
and then subjected to the same immunoprecipitation protocol as the
other constructs.
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Puriﬁcation of recombinant Oct4 and Trib2 proteins and
in vitro protein-protein interaction
His-tagged Oct4 and Trib2 maltose-binding protein (MBP) fusion
proteins were expressed in Escherichia coli and lysed in lysis buffer B
(50 mM Tris-HCl (pH 8.0), 100 mM NaCl, 1 mM EDTA, 0.2% Triton
X-100). Recombinant His-Oct4 and MBP-fused Trib2 proteins were
puriﬁed by afﬁnity chromatography on Ni-NTA agarose (Qiagen Inc.,
Valencia, CA, USA) or amylose agarose beads (New England Biolabs,
Ipswich, MA, USA) according to the manufacturer’s instructions.
Puriﬁed His-tagged Oct4 and MBP-fused Trib2 proteins were
incubated with pull-down buffer. After an additional 1 h of incuba-
tion, bound protein complexes were washed four times with binding
buffer. The resulting protein complexes were eluted from the beads by
boiling in 2× SDS sample buffer, resolved on SDS-PAGE, and
subjected to western blotting with anti-Trib2 antibodies.
Flow cytometry analysis
Oct4-GFP ES and iPS cells were analyzed on a FACS CantoΙΙ ﬂow
cytometer (BD Biosciences, San Jose, CA, USA). Ten thousand events
were acquired on a FACScan ﬂow cytometer (Becton Dickinson, San
Jose, CA, USA), and data analysis was performed using CellQuest
software (Becton Dickinson, San Jose, CA, USA).
Promoter luciferase assay
293FT cells were seeded on 12-well plates at a density of 1 × 105 cells
per well, followed by transfection of the Oct4 promoter in combina-
tion with pcDNA3.0-FLAG-Oct4 and p3×FLAG-CMV-Trib2 using
Lipofectamine-plus according to the manufacturer’s instructions. To
measure promoter activity in the self-regulatory loop, the CR4
promoter region of the mouse Oct4 promoter, which contains
Oct4-binding sites, was cloned by PCR ampliﬁcation of genomic
DNA (forward: 5′-ATGTCTCTTGTCCTGGCCAGTGAGTCACC-3′;
reverse: 5′-GCCTCAGCTTCATCGACTTCACCCG-3′). The resulting
fragment was subcloned into the KpnI and XhoI sites of the pGL3-
basic vector, followed by transfecting 293FT cells with pGL3-basic-
CR4 in combination with pcDNA3.0-FLAG-Oc4 and p3xFLAG-CMV-
Trib2. Luciferase activity was measured 2–4 days after infection/
transfection using the Dual-Luciferase Reporter Assay System and a
VICTOR3 Multilabel plate reader (Perkin Elmer, Santa Clara, CA,
USA). The pRL-SV40 plasmid served as an internal control for
normalizing transfection efﬁciency.
Chromatin immunoprecipitation
The chromatin immunoprecipitation (ChIP) assay for detecting Oct4
and FLAG-Trib2 in mES cells was performed as described previously.
In brief, ESCs were cross-linked with 1% formaldehyde for 10 min,
followed by formaldehyde inactivation by incubation with 125 mM
glycine and sonication in nuclear lysis buffer (50 mM HEPES, 1 mM
EDTA, 140 mM NaCl, 1% Triton X-100, 0.1% SDS). Chromatin
extracts containing DNA fragments with an average size of 300 bp
were immunoprecipitated using anti-Oct4, anti-FLAG or control
antibodies. ChIP DNA fragments were analyzed by qPCR (CR4 region
primer sequences: forward 5′-GGAACTGGGTGTGGGGAGGTTGT
A-3′; reverse: 5′-AGCAGATTAAGGAAGGGCTAGGACGAGAG-3′).
Production of retroviruses and lentiviruses
Retroviral plasmids carrying reprogramming factors (pMX-OCT4,
pMX-SOX2, pMX-KLF4 and pMX-c-Myc) were individually co-
transfected with packaging plasmids (gag-pol and VSV-G) into Plat-
GP cells using the Lipofectamine-plus reagent. Plat-GP cells (RV-103,
Cell Biolabs, Inc., San Diego, CA, USA) were maintained in DMEM
with high glucose, 10% FBS, 10 μgml−1 Blasticidin, and 1× penicillin-
streptomycin. To produce lentivirus expressing Trib2, the pLOVE-
Trib2 lentiviral expression vector was co-transfected into 293FT cells
with packaging plasmids (Δ 8.9 and VSV-G). Virus-containing
supernatants were collected 2 days after transfection, passed through
a 0.45-μm ﬁlter, and stored at −80 °C.
iPS cell generation
1× 105 MEFs were seeded in individual wells of six-well plates one day
prior to infection with retroviruses harboring Oct4, Sox2, Klf4, or
c-Myc (1:1:1:1 ratio, Polybrene (10 μgml−1). MEF media was renewed
the day after viral infection. On day 2 after infection, MEFs were
collected and re-seeded onto Mitomycin C-treated MEFs. The cell
media was switched to ES medium 5 days after infection, which was
then changed every other day. Cell morphology was monitored under
the microscope every day. After counting colonies on the indicated
days, the cells were subjected to further analysis.
Alkaline phosphatase (AP) staining and immunoﬂuorescence
staining
AP staining was performed for 30 min at room temperature in the
dark using the Vector Red AP Substrate Kit I according to the
manufacturer's protocol. The cells were incubated with substrate
solution at room temperature until suitable staining developed and
then photographed with a DFC300FX mounted digital camera (Leica,
Solms, Germany). For immunoﬂuorescence staining, mES or iPS cells
were ﬁxed in 4% paraformaldehyde in PBS for 10 min, washed twice
with PBS, and blocked with 1% FBS in PBS for 30 min; all procedures
were performed at room temperature. The ﬁxed specimens were
incubated with primary antibodies for 1 h, followed by incubation
with secondary antibodies for 1 h. The Oct4 (1:100; Santa Cruz
Biotechnology), Sox2 (1:100; Santa Cruz Biotechnology), Nanog
(1:100; cell signaling), SSEA-1 (1:100; Santa Cruz Biotechnology),
and Trib2 (1:100; Proteintech Group) primary antibodies were
detected by Alexa Fluor 488 and Alexa Fluor 568 conjugated secondary
antibodies (Thermo Fisher Scientiﬁc). The specimens were ﬁnally
washed and mounted in Vectashield medium with 4′,6-diamidino-2-
phenylindole for nuclei visualization. The stained sections were
visualized using laser scanning confocal microscopy (FluoView
FV1000, Olympus Corporation, Tokyo, Japan).
Teratoma formation and histological analysis
Animal experiments were performed using protocols approved by the
Pusan National University Institutional Animal Use and Care Com-
mittee. iPS cells were suspended at a density of 1× 107 cellsml−1 in
DMEM and mixed with Matrigel (BD Biosciences). BALB/CA-nu/nu
mice were anesthetized with an intraperitoneal injection of
400 mg kg− 1 2,2,2-tribromoethanol (Avertin; Sigma-Aldrich). In total,
100 μl of the cell suspension (1× 106 cells) was subcutaneously
injected into the dorsal ﬂanks of the mice. Four weeks after
transplantation, teratomas were surgically dissected from the mice.
Samples were rinsed once with PBS, ﬁxed in PBS containing 4%
formaldehyde, and embedded in parafﬁn. Sections were stained with
hematoxylin and eosin according to standard protocol.
Statistical analysis
Quantitative data are presented as the mean± s.d. from representative
experiments (n≥ 3). The role of chance in the observed differences was
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tested using unpaired Student’s t-test. Null hypotheses of no difference
were rejected if P-values were o0.05.
RESULTS
Trib2 expression is associated with ES cell pluripotency
Tribbles family members share strong sequence similarity in
their conserved pseudokinase domain.9 To evaluate the speci-
ﬁcity of Trib2, a Tribbles family member, in regulating
pluripotency, we examined Trib1, Trib2, Trib3 and Oct4
expression in mES cells, mES cell-derived mEBs, and further-
differentiated EBs on day 10 (Diff-d10) using RT-PCR analysis.
As shown in Figure 1a, Oct4 and Trib2 expression was similarly
decreased during spontaneous mES cell differentiation. How-
ever, Trib1 and Trib3 expression was not signiﬁcantly affected
during the differentiation of mESs. Quantitative analysis of the
expression levels using real-time PCR showed decreased Trib2
and Oct4 expression during the spontaneous differentiation of
mES cells into day 10 differentiated mEBs, whereas the mRNA
levels of Trib1 and Trib3 were not changed (Figure 1b).
Expression of the differentiation marker Nestin was signiﬁ-
cantly increased when mES cells differentiated into day 10
mEBs. These results suggest that Trib2 may be implicated in
regulating the pluripotent state of mES cells.
Trib2 is required for ES cell pluripotency maintenance
To investigate whether Trib2 is necessary for maintaining the
pluripotent phenotype of mES cells, Trib2 expression was
knocked down by shRNAs. As shown in Figure 2a, Trib2
shRNA knockdown resulted in morphologically changed mES
cells, including reduced colony size and loss of AP activity,
which is indicative of differentiation. In addition, when Trib2
expression was knocked down in OG2/ROSA26 mES cells,
which express GFP under control of the Oct4 promoter, the
GFP-positive cell population was signiﬁcantly decreased
(Figure 2b). Quantitative analysis by ﬂow cytometry showed
that the GFP-positive cell population decreased from 50% to
16.9% after Trib2 knockdown. RT-PCR analysis showed that
Trib2 knockdown signiﬁcantly decreased the expression of
Oct4, Sox2 and Nanog, whereas the expression of Trib1 and
Trib3 did not decrease to the same extent as Oct4 (Figure 2c).
Immunocytochemistry analysis showed that Trib2 knockdown
substantially decreased the expression of Oct4, Sox2, and
SSEA-1 (Figure 2d). To exclude shRNA off-target effects, we
performed a rescue experiment. The shRNA used to knock
down Trib2 was speciﬁc to mouse endogenous Trib2. To
perform the rescue experiment, we generated a mES cell line
expressing FLAG-tagged human TRIB2. As shown in Figure 2e,
knocking down endogenous Trib2 in mES cells decreased the
AP-positive colony sizes and numbers. However, ES cells
expressing human FLAG-TRIB2 showed little change in their
AP-positive colony sizes and numbers after endogenous Trib2
knockdown. The RT-PCR results conﬁrmed successful mouse
Trib2 knockdown and human TRIB2 expression (Figure 2e,
lower panel). These results strongly suggest that Trib2 expres-
sion is required for mES cells to maintain the pluripotent
phenotype.
Trib2 speciﬁcally interacts with Oct4
To examine whether a direct interaction exists between Trib2
and core pluripotency factors, such as Oct4 and Sox2,13,14 we
performed pull-down assays in 293FT cells. After co-
transfecting 293FT cells with FLAG-tagged Trib2 and TAP-
tagged Oct4 or TAP-tagged Sox2, Oct4 and Sox2 were pulled
down with streptavidin beads targeting the TAP tag. As shown
in Figure 3a, the Oct4 pull-down co-precipitated Trib2 whereas
the Sox2 pull-down did not. Using the opposite approach in
which cell lysates were pulled down with anti-FLAG antibodies,
Oct4 co-precipitated with Trib2 whereas Sox2 did not
(Figure 3b). Immunocytochemistry of mES colonies showed
Oct4 and Trib2 co-localization in the nucleus (Supplementary
Figure S1). Furthermore, immunoprecipitation with an anti-
FLAG antibody in ES cells after FLAG-Trib2 transfection
showed that Oct4 co-immunoprecipitated with Trib2
(Figure 3c). These results strongly suggest that endogenous
Oct4 and Trib2 interact in ES cells.
Figure 1 Downregulation of Trib2 expression during embryonic stem (ES) cell differentiation. (a) Results of the reverse transcription PCR
(RT-PCR) analysis of mouse ES cells (mES) cells, embryonic bodies (EB) and day 10 embryonic bodies (Diff-d10) with probes for Oct4
and the Trib family are shown. The mRNA levels of the Trib family were visualized after 22 cycles of ampliﬁcation using primers speciﬁc
for each Trib isoform. (b) The real-time PCR results of mES cells and day 10 embryonic bodies (Diff-d10) with probes for Trib family
members, a stem cell marker (Oct4) and a differentiation marker (Nestin) are shown. The experiments were conducted in triplicate and
normalized to β-actin. *Po0.05 by Student’s t-test.
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Oct4 has POU DNA-binding domains (POUS and POUH)
and N-terminal and C-terminal transactivation domains
(TAD1 and TAD2).15 To identify the Trib2-interacting regions
of Oct4, we utilized a series of Oct4 truncation mutants, as
shown in Figure 3d (upper panel).16 After co-transfecting
293FT cells with FLAG-Oct4 or each of the FLAG-Oct4
truncation mutants with TAP-Trib2, they were pulled down
with anti-FLAG antibodies. As shown in Figure 3d (lower
panel), full-length Oct4 and the ΔTAD2, N-half, ΔTAD1, POU
and ΔPOUH truncation mutants, which all contain the POUS
Figure 2 Effect of Trib2 knockdown on the maintenance of mouse embryonic stem (mES) cells. (a) Trib2 expression was knocked down in
D3 mES cells. Bright ﬁeld and alkaline phosphatase (AP) staining images of ES cell colonies from control and Trib2 knockdown cells are
shown. Scale bar=50 μm. (b) Trib2 expression was knocked down in Oct4-GFP mES cells. Bright ﬁeld and ﬂuorescence images of
representative colonies from control and Trib2 knockdown cells are shown (left panel). Scale bar=50 μm. Results of the ﬂow cytometry
analysis of Oct4-GFP mES cells with or without Trib2 knockdown along with mouse embryonic ﬁbroblasts (MEFs) are shown (right panel).
(c) Results of the reverse transcription PCR (RT-PCR)analysis of mES cells with or without Trib2 knockdown with the indicated probes are
shown. (d) Fluorescence microscopy images of mES cell colonies with or without Trib2 knockdown are shown after labeling the cells with
antibodies against Trib2 (red color) or Oct4 (green color) and 4′-6-Diamidino-2-phenylindole (DAPI, blue color) and overlaid images are
shown. Scale bar=20 μm. (e) The rescue of Trib2 knockdown with human TRIB2 (hTRIB2) in mES cells. Mouse Trib2 (mTrib2) was
knocked down by mTrib2-speciﬁc shRNA in mES cells or mES cells overexpressing hTRIB2, followed by AP staining (upper panel).
Scale bar=50 μm. The expression levels of mTrib2, hTRIB2, and GAPDH were detected by RT-PCR analysis on day 4 after infection
(lower panel).
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domain, interacted with Trib2. The ΔPOU and TAD1 trunca-
tion mutants, which contain TAD1 or TAD2 but not the POU
domain, did not interact with Trib2. These results suggest that
the POUS domain in Oct4 is important for its interaction with
Trib2. In addition, when puriﬁed His-tagged Oct4 and MBP-
fusion Trib2 were incubated in vitro, a MBP-fused Trib2 pull-
down co-precipitated His-tagged Oct4, which suggests a direct
interaction between Oct4 and Trib2 (Figure 3e). Oct4 is well
known to bind Sox2. To examine whether the Trib2 interaction
with Oct4 inﬂuences the Oct4-Sox2 interaction, we performed
an experiment to evaluate the competitive binding of Trib2 and
Sox2 to Oct4. 293FT cells were co-transfected with Oct4 in
combination with Trib2 and/or Sox2. Individual transfection of
Trib2 or Sox2 with Oct4 showed co-precipitation of Trib2 or
Sox2 when Oct4 was pulled down (Supplementary Figure S2).
However, when Trib2, Sox2, and Oct4 were simultaneously co-
transfected, a decrease in Trib2 and Sox2 co-precipitation was
observed when Oct4 was pulled down. These results suggest
that Trib2 may compete with Sox2 for Oct4 binding. Taken
together, these results indicate that the speciﬁc and direct
Figure 3 Identiﬁcation of the interaction between Trib2 and Oct4. (a) 293FT cells were transiently transfected with N-terminal streptavidin
binding peptide-tagged Oct4 (TAP-Oct4) or N-terminal streptavidin binding peptide-tagged Sox2 (TAP-Sox2) in combination with FLAG-
tagged Trib2 (FLAG-Trib2). Results of the western blot analysis of total cell lysates and the precipitates pulled down with the TAP tag after
probing with anti-Trib2, anti-Oct4 or anti-Sox2 antibodies are shown. (b) The same cell lysates were pulled down with a FLAG tag, and the
western blot analysis results with the anti-Oct4, anti-Sox2 and anti-FLAG antibodies are shown. (c) Interaction of endogenous Trib2 and
Oct4 in mES cells. ES cell lysates were subjected to western blot analysis after transfection with FLAG-Trib2 (left panel). FLAG-Trib2 was
immunoprecipitated from ES cell lysates, followed by Western blot analysis with the indicated antibodies (right panel). (d) A schematic
representation of full-length FLAG-Oct4 and the FLAG-Oct4 deletion constructs along with the Trib2 binding results are shown (upper
panel). 293FT cells were transiently transfected with full-length FLAG-Oct4 or each FLAG-Oct4-deletion construct plus Trib2. Results of
the western blot analysis of 293FT cell lysates and the precipitates pulled down with an anti-FLAG antibody after probing with anti-FLAG
or anti-Trib2 antibodies are shown (lower panel). (e) MBP-Trib2 and MBP-control proteins were expressed in E. coli and immobilized to
amylose resin. Puriﬁed His-Oct4 was incubated with puriﬁed MBP-Trib2 and MBP-control proteins, and the MBP-tagged proteins were
precipitated. The level of Oct4 bound to MBP-Trib2 was determined by Western blotting (upper panel). The MBP-Trib2 inputs and the
MBP control protein are shown in the lower panel.
Role of Trib2 in somatic cell reprogramming
EK Do et al
6
Experimental & Molecular Medicine
interaction between Oct4 and Trib2 could be mediated through
the POUS domain in Oct4.
Trib2 positively regulates Oct4 transcriptional activity
Oct4 activates its own promoter.17,18 To examine whether
Trib2 is involved in activating the Oct4 promoter, we
performed a transcription reporter assay by co-transfecting
NIH3T3 cells with a luciferase reporter driven by a 3 kb
upstream region of the Oct4 promoter in combination with
Trib2 and Oct4. As shown in Figure 4a, single Trib2 or Oct4
transfection with the reporter increased the Oct4 transcrip-
tional activity signiﬁcantly. Trib2 and Oct4 co-transfection,
however, was synergistic, and dramatically increased the Oct4
transcriptional activity. To further characterize the synergism
between Trib2 and Oct4 in regulating Oct4 transcription, we
utilized an Oct4 CR4 (conserved region 4)-driven luciferase
reporter.16 NIH3T3 cells were co-transfected with the Oct4
CR4-driven luciferase reporter in combination with Trib2 and
Oct4. As shown in Figure 4b, Trib2 or Oct4 alone increased the
CR4 enhancer activity, and co-transfection of Trib2 and Oct4
increased the CR4 enhancer activity even more. To investigate
whether Trib2 occupies the endogenous Oct4 promoter, we
examined the binding of Trib2 to the endogenous Oct4
promoter in mES cells. As shown in Figure 4c, a comparison
of chromatin immunoprecipitation results using an Oct4
antibody or a FLAG antibody after FLAG-Trib2 transfection
to those using control IgGs showed speciﬁc binding of Oct4
and Trib2 to the CR4 region of the Oct4 promoter. These
results suggest that Oct4 and Trib2 occupy the endogenous
Oct4 promoter. Taken together, these results show that Trib2
plays a critical role in regulating Oct4-driven Oct4 transcrip-
tional activity.
Trib2 regulates the efﬁciency of somatic cell reprogramming
into iPS cells
To investigate whether Trib2 contributes to the reprogramming
process in the generation of iPS cells from somatic cells, we
examined the effect of Trib2 knockdown during the generation
of iPS cells from mouse MEFs. MEFs were infected with
retroviruses encoding four core transcription factors (Oct4,
Figure 4 The role of Trib2 in regulating the Oct4 promoter activity. (a) NIH3T3 cells were transfected with a 3- kb upstream sequence of
the Oct4 promoter-driven luciferase construct in combination with single or double Oct4 and/or Trib2 transfection. The luciferase activities
were determined on day 2 after transfection. (b) NIH3T3 cells were transfected with the CR4 region of the Oct4 promoter-driven luciferase
construct in combination with single or double Oct4 and/or Trib2 transfection. The luciferase activities were determined on day 2 after
transfection. *Po0.05 by Student’s t-test. (c) Chromatin immunoprecipitation (ChIP) analysis of the CR4 region of the endogenous Oct4
promoter. Mouse ES cells expressing FLAG-Trib2 were subjected to ChIP with the indicated antibodies, and qPCR results after
normalization to the IgG control are shown. ‘*’ indicates po0.05 versus the control antibody.
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Sox2, Klf4 and c-Myc) together with lentiviral shRNA against
Trib2 (sh-Trib2). As shown in Figure 5a, sh-Trib2 successfully
decreased Trib2 expression in MEFs. Introducing Oct4, Sox2,
Klf4 and c-Myc (OSKM) into MEFs successfully generated iPS
cell colonies, and AP staining on day 28 after infection showed
AP-positive colonies. However, Trib2 knockdown along with
OSKM signiﬁcantly decreased the generation of iPS cell
colonies and AP-positive colonies (Figure 5b and c). RT-PCR
and immunochemical analysis showed that iPS cells generated
with OSKM expressed the pluripotency marker genes Oct4,
Sox2, Nanog and Klf4 (Figure 5d and e). However, Trib2
knockdown and OSKM signiﬁcantly decreased the expression
of Oct4, Sox2, Nanog and Klf4 in the generated cells
(Figure 5d). These results suggest that Trib2 expression is
required to reprogram somatic cells into iPS cells. We next
evaluated whether the overexpression of Trib2 could enhance
reprogramming efﬁciency. We introduced retroviruses encod-
ing OSKM into Oct4-GFP MEFs with or without lentiviral
Trib2 overexpression. As shown in Figure 6a, the lentiviral
introduction of Trib2 increased the expression of Trib2 in
Oct4-GFP MEFs. When OSKM retroviruses were introduced
along with Trib2 overexpression, the AP-positive and GFP-
positive iPS cell colony numbers were signiﬁcantly increased
compared to cells transduced with only OSKM (Figure 6b
and c). Flow cytometry analysis of reprogramming cells showed
that Trib2 overexpression signiﬁcantly increased the OSKM-
induced GFP-positive cell population (Figure 6d). In addition,
iPS cells generated from OSKM introduction along with Trib2
overexpression successfully generated teratomas in nude mice
(Figure 6e). These results suggest that additional Trib2 expres-
sion during the reprogramming process enhances the efﬁciency
of iPS cell generation.
Figure 5 The effect of Trib2 knockdown during the reprogramming of mouse embryonic ﬁbroblasts (MEFs) into iPS cells. (a) The RT-PCR
results of MEFs with or without Trib2 knockdown with the indicated probes are shown. Trib2 was visualized after 30 cycles of
ampliﬁcation using Trib2-speciﬁc primers. (b) MEFs were reprogrammed into iPS cells by the retroviral transduction of Oct4, Sox2, Klf4
and c-Myc with or without Trib2 knockdown. The alkaline phosphatase (AP) staining of colonies (upper and middle panels) and bright ﬁeld
images of colonies on day 28 after transduction are shown. Scale bar=50 μm. (c) The quantitative analysis of AP-positive colonies is
shown. *Po0.05 by Student’s t-test. (d) The RT-PCR results of iPS colonies on day 28 with or without Trib2 knockdown, mES cells and
MEFs with the indicated probes are shown. (e) Immunocytochemical images of iPS colonies on day 28 after the retroviral transduction of
MEFs with Oct4, Sox2, Klf4 and c-Myc with the indicated antibodies are shown. Scale bar=30 μm.
Role of Trib2 in somatic cell reprogramming
EK Do et al
8
Experimental & Molecular Medicine
In summary, for the ﬁrst time, we report that Trib2 is a
speciﬁc and important factor in the maintenance of mES cell
pluripotency. Trib2 shows synergism with Oct4 to positively
regulate Oct4 promoter activity. Furthermore, Trib2 is a critical
factor during the reprograming of somatic cells into iPS cells.
These results will contribute to understanding the mechanisms
underlying pluripotency regulation, which may bring clinical
regenerative medicine a step closer.
DISCUSSION
In the present study, we demonstrated that Trib2 is an important
regulator of ES cell self-renewal and pluripotency induction
during the reprogramming process. Unique transcription factors
in pluripotent cells form a complex network.17 The expression
levels of Trib2 in mES cells and differentiated EBs resemble those
of Oct4, an important regulator of pluripotency in undifferen-
tiated ES cells. The pluripotent state-speciﬁc gene expression
patterns of ES cells can indicate inﬂuential clues that maintain
their characteristics, such as self-renewal and differentiation
potential. Numerous genes whose expression decreases during
ES cell differentiation have been identiﬁed,19 and several are
required to maintain ES cell pluripotency.20,21 These observations
led to our hypothesis that Trib2 is important for maintaining the
pluripotent state. We observed that upon shRNA-mediated Trib2
knockdown, ES cells failed to maintain pluripotency. We also
observed decreased Oct4, Sox2, Nanog and SSEA-1 expression
Figure 6 Effect of Trib2 overexpression during the reprogramming of mouse embryonic ﬁbroblasts (MEFs) into iPS cells. (a) Western blot
results of MEFs with or without the lentiviral overexpression of Trib2 with the indicated antibodies. (b) Oct4 promoter-driven GFP MEFs
were infected with Oct4, Sox2, Klf4 and c-Myc retroviruses in combination with Trib2-overexpressing lentivirus. The alkaline phosphatase
(AP) staining of colonies (upper and middle panels) and ﬂuorescence images of GFP-positive colonies on day 16 after transduction are
shown. Scale bar=50 μm. (c) The quantitative analysis of GFP-positive colonies is shown. *Po0.05 by Student’s t-test. (d) The ﬂow
cytometry results of iPS colonies on day 16 after Oct4-GFP MEFs were infected with Oct4, Sox2, Klf4 and c-Myc retroviruses in
combination with Trib2-overexpressing lentivirus are shown. (e) H&E staining images of teratomas generated from iPS cells with the viral
transduction of MEFs with Oct4, Sox2, Klf4, c-Myc and Trib2 are shown. Scale bar=100 μm.
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and abnormal ES cell colony formation in mES cells. These
results illustrate the novel aspects of Trib2 in pluripotency
induction and maintenance.
We demonstrated a protein-protein interaction between
Trib2 and Oct4 using afﬁnity puriﬁcation methods,22 which
allow proteins associated with a target protein to be identiﬁed.
Oct4 is a master regulator in ES cell development.23 Oct4-
interacting proteins are usually identiﬁed in human cancers
and other diseases by afﬁnity puriﬁcation, and they possess
functional signiﬁcance related to differentiation, signaling and
transcriptional activity.24 Oct4 contains a POU-speciﬁc DNA-
binding domain (POUS) with a POU homeodomain (POUH)
as well as transactivation domains located at its N- (TAD1) and
C-termini (TAD2).25,26 Interestingly, the Oct4 POU domain is
an essential regulator in maintaining the self-renewal and
pluripotent potential of ES cells.27 In addition, POUH is
involved in forming the Oct4-Sox2 complex.28 Our data
indicate that the Trib2-interacting region of Oct4 is not
observed with other transactivation domains but appears to
be speciﬁc for the POU domain. Therefore, these results
suggest that Trib2 directly interacts with Oct4. Moreover,
Trib2 showed a similar binding pattern to Oct4 in the CR4
region (Figure 4c). Trib2 does not have a DNA-binding
domain. Therefore, Trib2 likely binds to the CR4 region via
binding Oct4, although the molecular mechanism underlying
the Trib2-dependent activation of the Oct4 promoter needs to
be clariﬁed further.
Our ﬁndings in the present study have revealed the essential
function of Trib2 in maintaining and establishing ES cell
pluripotency. iPS cells closely resemble ES cells in their inﬁnite
growth capacity and their ability to differentiate into diverse
cell lineages. Investigating the functional proteins and interac-
tion networks involved in the reprogramming process is
important to understand the molecular mechanisms under-
lying pluripotency establishment. Our data demonstrated that
inducing Trib2 loss of function by shRNA during the
reprogramming process interfered with colony formation, ES
cell marker expression and AP activity. In addition, GFP-
expressing colonies in which OSKM was introduced and Trib2
was overexpressed were found to have a more efﬁcient
reprogramming process than the control. These data suggest
that Trib2 regulates reprogramming efﬁciency in iPS cell
generation, implying that Trib2 contributes to the establish-
ment of pluripotency.
Trib2 was identiﬁed as an oncogene that induces acute
myelogenous leukemia (AML) via a mechanism involving the
downregulation of C/EBPα.29 Among Tribbles family mem-
bers, Trib1 and Trib2 induced AML from hematopoietic stem
cells whereas Trib3 did not.30 To reprogram B cells into iPS
cells with inducible OSKM expression, ectopic C/EBPα expres-
sion was necessary.31 While reprogramming mouse primary B
cells by OSKM, transient C/EBPα expression with Oct4
expression increased the efﬁciency of iPS cell generation by
100-fold in 2 days, suggesting that C/EBPα functions as a
‘path-breaker’.32 A recent report showed that in AML, the
elevated expression of C/EBPα p42 and left p30, an oncogenic
isoform, and the complete absence of C/EBPα expression
abrogated the induction of AML by Trib2.33 In melanoma,
TRIB2 acts as an oncogene by suppressing FOXO, which
regulates the identity of human ES cells.21,34 Though the
detailed molecular mechanism of how Trib2 contributes to
the reprogramming process currently remains elusive, our
ﬁndings suggest that Trib2 is a critical factor in maintaining
and inducing pluripotency.
In summary, the novel aspect of our study is that Trib2
maintains pluripotency and progresses cellular reprogramming.
Trib2 expression was downregulated in differentiated ES cells,
and Trib2 depletion reduced the pluripotency of ES cells. In
support of these results, we demonstrated that Oct4, an
essential regulator of pluripotency, directly interacts with Trib2,
and its interaction increases Oct4 promoter activity. Finally,
Trib2 facilitates iPS cell generation through the Trib2/Oct4
complex.
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